Test description
Testing of genes associated with inherited endocrine neoplasia syndromes in patients with endocrine tumours or suggestive clinical or family history.
Test information
BRAoVOTM Endocrine Gene panel
Used to determine pathogenic variant status in patients with a clinical diagnosis of MEN2, plus determine risk for patients with persona and/or family history suggestive of GIST or other endocrine tumours.
AIP, APC, CDC73, CDKN1B, DICER1, FH, KIT, MAX, MEN1, NF1, PDGFRA, PRKAR1A, PTEN, RET, SDHA, SDHAF2, SDHB, SDHC, SDHD, SEC23B, TMEM127, VHL, WRN
Massively parallel sequencing
4 - 5 weeks
73339 - conditions apply
$499 if Medicare criteria not met.
Cancer genetics test request form preferred. Standard pathology request form accepted.
Blood x 2
EDTA
2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to provide consent prior to testing.